Autolus Therapeutics Plc (AUTL)

1.61 +0.02 (+1.26%) USD  |  NASDAQ  |  Dec 12, 16:00
1.62 +0.01 (+0.62%) After-Hours: 20:00
More

Autolus Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for AUTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Adaptimmune Therapeutics Plc Upgrade
Biodexa Pharmaceuticals Plc --
NuCana Plc --
Mereo BioPharma Group Plc --
Bicycle Therapeutics Plc Upgrade